Keywords chroniclymphocyticleukemia;CLLflowscoresystem;flowcytometry;CD200 B 细胞慢性淋巴细胞增 殖性疾病(Bcellchro- niclymphoproliferativedisorders,B-CLPD)是一 组在形态学和免疫表型特征以及临床行为上均有 异质性的疾病 .[1] 由于不同疾病类别的临床演变 和治疗反应可 能不同,因此正确的诊断至关重要. 流...
Diagnosis of CLL revisited: increased specificity by a modified five‐marker scoring system including CD200doi:10.1111/bjh.14901The modified Matutes score has been the basis for the diagnosis of chronic lymphocytic leukaemia (CLL) by flow cytometry for the past 15 years. To increase the ...
Response assessment after FCR therapy included routine clinical and laboratory assessments, radiographic imaging of CLL manifestations (used method at the discretion of the local investigator), and flow cytometry for minimal residual disease (MRD) assessment. The latter was performed using four-color ...
Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia. Cytometry B Clin Cytom 2009; 76: 385–393. Article PubMed Google Scholar Kern W, Bacher U, Haferlach C,...
Circulating cells from 666 cases were analyzed with a panel of markers by flow cytometry. The diseases included: chronic lymphocytic leukemia (CLL), 400; prolymphocytic leukemia, 22; hairy cell leukemia (HCL), 40; HCL variant, 15; splenic lymphoma with villous lymphocytes, 1...